DRRX logo

Durect Corp

DRRX

DRRX: Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .

more

Show DRRX Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of DRRX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by DRRX's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $20,000 Feb 11, 2008 Issue: Defense
  • $40,000 Aug 07, 2007 Issue: Defense
  • $40,000 Feb 12, 2007 Issue: Defense
  • $40,000 Aug 08, 2006 Issue: Defense
  • $40,000 Feb 14, 2006 Issue: Defense
U.S. Patents

New patents grants

  • Patent Title: Uses of oxygenated cholesterol sulfates (ocs) Mar. 28, 2023
  • Patent Title: Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same Dec. 20, 2022
  • Patent Title: Sustained release drug delivery systems with reduced impurities and related methods Aug. 02, 2022
  • Patent Title: Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material Mar. 29, 2022
  • Patent Title: Short duration depot formulations Nov. 23, 2021
  • Patent Title: Peroxide removal from drug delivery vehicle Aug. 10, 2021
  • Patent Title: Uses of oxygenated cholesterol sulfates (ocs) Sep. 29, 2020
  • Patent Title: Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same Sep. 01, 2020
  • Patent Title: Depot formulations Jun. 16, 2020
  • Patent Title: Depot formulations Jun. 02, 2020
  • Patent Title: Short duration depot formulations Nov. 12, 2019
  • Patent Title: Short duration depot formulations Nov. 12, 2019
  • Patent Title: Oral pharmaceutical dosage forms Jun. 25, 2019
  • Patent Title: Compositions with a rheological modifier to reduce dissolution variability May. 28, 2019
  • Patent Title: Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material Mar. 12, 2019
  • Patent Title: Oral pharamaceutical dosage forms Feb. 19, 2019
  • Patent Title: Short duration depot formulations Feb. 12, 2019
  • Patent Title: Depot formulations Jul. 24, 2018
  • Patent Title: Oral drug delivery system Mar. 20, 2018
  • Patent Title: Compositions with a rheological modifier to reduce dissolution variability Mar. 06, 2018
  • Patent Title: Oral pharmaceutical dosage forms Feb. 06, 2018
  • Patent Title: Compositions with a rheological modifier to reduce dissolution variability Jan. 02, 2018
  • Patent Title: Injectable controlled release composition comprising high viscosity liquid carrier Aug. 22, 2017
  • Patent Title: Oral pharmaceutical dosage forms May. 23, 2017
  • Patent Title: Oral pharmaceutical dosage forms Apr. 11, 2017
  • Patent Title: Sustained release small molecule drug formulation Mar. 21, 2017
  • Patent Title: Oral pharmaceutical dosage forms Mar. 14, 2017
  • Patent Title: Compositions with a rheological modifier to reduce dissolution variability Feb. 21, 2017
  • Patent Title: Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material Feb. 21, 2017
  • Patent Title: Compositions with a rheological modifier to reduce dissolution variability Jan. 31, 2017
  • Patent Title: Oral drug delivery system Dec. 13, 2016
  • Patent Title: Oral drug delivery system Jan. 12, 2016
  • Patent Title: Sustained release small molecule drug formulation Jun. 02, 2015
  • Patent Title: Oral drug delivery system Mar. 10, 2015
  • Patent Title: Transdermal delivery systems Feb. 17, 2015
  • Patent Title: Oral drug delivery system Feb. 10, 2015
  • Patent Title: Oral drug delivery system Feb. 03, 2015
  • Patent Title: Zero-order prolonged release coaxial implants Nov. 18, 2014
  • Patent Title: Sustained release small molecule drug formulation Oct. 07, 2014
  • Patent Title: Controlled delivery system Sep. 30, 2014
  • Patent Title: Injectable, non-aqueous suspension with high concentration of therapeutic agent Aug. 12, 2014
  • Patent Title: Controlled delivery system Jun. 17, 2014
  • Patent Title: Transdermal analgesic systems with reduced abuse potential Jun. 10, 2014
  • Patent Title: Polymeric device for controlled release of active agents May. 13, 2014
  • Patent Title: Polymeric devices for controlled release of active agents Feb. 11, 2014
  • Patent Title: Non-aqueous single phase vehicles and formulations utilizing such vehicles Jul. 30, 2013
  • Patent Title: Transdermal analgesic systems with reduced abuse potential May. 14, 2013
  • Patent Title: Oral drug delivery system Apr. 16, 2013
  • Patent Title: Oral pharmaceutical dosage forms Apr. 09, 2013
  • Patent Title: Oral drug delivery system Jan. 15, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of DRRX in WallStreetBets Daily Discussion

DRRX News

Recent insights relating to DRRX

CNBC Recommendations

Recent picks made for DRRX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DRRX

Corporate Flights

Flights by private jets registered to DRRX